FFAR2 and infection: These results are also consistent with recent findings showing that targeted activation of GPR43 reduces susceptibility to infection by bacteria such as Staphylococcus aureus, Citrobacter rodentium, and Klebsiella pneumonia, as well as viruses like respiratory syncytial and influenza viruses (26).